Skip to main content

Blog

Introducing PPMD’s Dystrophinopathy Clinical Research Network (DCRN): Advancing the Research Evolution

...

Avidity Biosciences Announces Plans to File Biologics License Application for Delpacibart Zotadirsen (AOC 1044)

...

PPMD’s Race to End Duchenne Program Celebrates 20 Years of Going the Distance to End Duchenne

...

Thank You for Joining us to Advance the Research Evolution

...

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel

...

Double your impact in advancing the research evolution by the end of 2024

...

Give before midnight TONIGHT to double your impact in developing PPMD’s DCRN

...

Together, let’s advance the research evolution

...

Life is about time and timing when living with Duchenne

...

WATCH: Sevasemten – CANYON Trial Topline Results (Webinar Recording)

...